N. Dimmock

发表

Deletion Analysis of a Defective Interfering Semliki Forest Virus RNA Genome Defines a Region in the nsP2 Sequence That Is Required for Efficient Packaging of the Genome into Virus Particles

C. White, M. Thomson, N. Dimmock, 1998, Journal of Virology.

Identification of the sequence responsible for the nuclear accumulation of the influenza virus nucleoprotein in Xenopus oocytes

J. Davey, N. Dimmock, A. Colman, 1985, Cell.

Quantitative relationships between an influenza virus and neutralizing antibody.

N. Dimmock, H. P. Taylor, S. Armstrong, 1987, Virology.

Location of influenza virus M, NP and NS1 proteins in microinjected cells.

J. Davey, N. Dimmock, A. Colman, 1985, The Journal of general virology.

Introduction to Modern Virology

N. Dimmock, A. Easton, K. Leppard, 1974 .

Defective interfering viruses and their potential as antiviral agents

N. Dimmock, N J Dimmock, A. Marriott, 2010, Reviews in medical virology.

An antibody specific for the C-terminal tail of the gp41 transmembrane protein of human immunodeficiency virus type 1 mediates post-attachment neutralization, probably through inhibition of virus-cell fusion.

N. Dimmock, C. Heap, Steven A Reading, 2005, The Journal of general virology.

Cloned Defective Interfering Influenza Virus Protects Ferrets from Pandemic 2009 Influenza A Virus and Allows Protective Immunity to Be Established

M. Carroll, N. Dimmock, A. Easton, 2012, PloS one.

Defective interfering virus protects elderly mice from influenza

N. Dimmock, A. Easton, A. Marriott, 2011, Virology Journal.

Stimulation of neutralizing antibodies to human immunodeficiency virus type 1 in three strains of mice immunized with a 22 amino acid peptide of gp41 expressed on the surface of a plant virus.

G. Lomonossoff, N. Dimmock, C. Porta, 1996, Vaccine.

The Encounter of the Microbe with the Phagocytic Cell

N. Dimmock, A. Nash, C. Mims, 1995 .

Characterization of a human immunodeficiency virus type 1 pre-integration complex in which the majority of the cDNA is resistant to DNase I digestion.

N. Dimmock, Dheeraj K Khiytani, 2002, The Journal of general virology.

Insights into neutralization of animal viruses gained from study of influenza virus

N. Dimmock, M. Outlaw, 1991, Epidemiology and Infection.

Part of the C-terminal tail of the envelope gp41 transmembrane glycoprotein of human immunodeficiency virus type 1 is exposed on the surface of infected cells and is involved in virus-mediated cell fusion.

N. Dimmock, Mark J Hollier, Steven A Reading, 2005, The Journal of general virology.

Postattachment neutralization of a primary strain of HIV type 1 in peripheral blood mononuclear cells is mediated by CD4-specific antibodies but not by a glycoprotein 120-specific antibody that gives potent standard neutralization.

N. Dimmock, T. McInerney, 2001, AIDS research and human retroviruses.

Variations in the neutralizing and haemagglutination-inhibiting activities of five influenza A virus-specific IgGs and their antibody fragments.

J. Stephenson, N. Dimmock, D. Schofield, 1997, The Journal of general virology.

Summary of antibody workshop: The Role of Humoral Immunity in the Treatment and Prevention of Emerging and Extant Infectious Diseases.

D. Morens, N. Dimmock, R. Krause, 1997, The Journal of infectious diseases.

Categorization of nucleoproteins and matrix proteins from type A influenza viruses by peptide mapping.

R. Webster, N. Dimmock, A. Carver, 1980, Virology.

Protection of mice from lethal influenza by defective interfering virus: T cell responses.

N. Dimmock, L. McLain, D. J. Morgan, 1992, The Journal of general virology.

Neutralization of animal virus infectivity by antibody

N. Dimmock, Steven A Reading, S. A. Reading, 2007, Archives of Virology.

Phosphorylation of influenza virus nucleoprotein in vivo.

N. Dimmock, T. Petri, 1981, The Journal of general virology.

Antiviral Activity of Defective Interfering Influenza Virus in vivo

N. Dimmock, 1996 .

Defective Interfering Influenza Virus RNAs: Time To Reevaluate Their Clinical Potential as Broad-Spectrum Antivirals?

N. Dimmock, A. Easton, 2014, Journal of Virology.

Semliki Forest virus infection of mice: a model for genetic and molecular analysis of viral pathogenicity.

G. Atkins, N. Dimmock, B. Sheahan, 1985, The Journal of general virology.

Mechanism of neutralization of influenza virus by secretory IgA is different from that of monomeric IgA or IgG

N. Dimmock, H. P. Taylor, 1985, The Journal of experimental medicine.

All rabbits immunized with type A influenza virions have a serum haemagglutination-inhibition antibody response biased to a single epitope in antigenic site B.

N. Dimmock, R. Lambkin, 1995, The Journal of general virology.

A Defective Interfering Influenza RNA Inhibits Infectious Influenza Virus Replication in Human Respiratory Tract Cells: A Potential New Human Antiviral

N. Dimmock, A. Easton, C. Smith, 2016, Viruses.

Mechanisms of Cell and Tissue Damage

N. Dimmock, A. Nash, C. Mims, 1995, Mims' Pathogenesis of Infectious Disease.

IgG neutralization of type A influenza viruses and the inhibition of the endosomal fusion stage of the infectious pathway in BHK cells.

N. Dimmock, M. Outlaw, 1993, Virology.

The receptor preference of influenza viruses

N. Dimmock, A. Marriott, B. Meng, 2010, Influenza and other respiratory viruses.

Defective segment 1 RNAs that interfere with production of infectious influenza A virus require at least 150 nucleotides of 5' sequence: evidence from a plasmid-driven system.

N. Dimmock, S. Duhaut, 2002, The Journal of general virology.

Approximately 150 nucleotides from the 5' end of an influenza A segment 1 defective virion RNA are needed for genome stability during passage of defective virus in infected cells.

N. Dimmock, S. Duhaut, 2000, Virology.

Proteins Specified by Influenza Virus in Infected Cells: Analysis by Polyacrylamide Gel Electrophoresis of Antigens Not Present in the Virus Particle

N. Dimmock, D. Watson, 1969 .

Intracellular stability of the gene encoding influenza virus haemagglutinin.

N. Dimmock, C. Cane, 1990, Virology.

Intracellular stability of the interfering activity of a defective interfering influenza virus in the absence of virus multiplication.

N. Dimmock, L. McLain, C. Cane, 1987, Virology.

Valency of antibody binding to virions and its determination by surface plasmon resonance

N. Dimmock, Sam A. Hardy, 2004, Reviews in medical virology.

Mechanisms of neutralization of influenza virus in tracheal epithelial and BHK cells vary according to IgG concentration.

N. Dimmock, S. Armstrong, M. Outlaw, 1990, Virology.

Mechanisms of neutralization of influenza virus on mouse tracheal epithelial cells by mouse monoclonal polymeric IgA and polyclonal IgM directed against the viral haemagglutinin.

N. Dimmock, M. Outlaw, 1990, The Journal of general virology.

Fowl plaque virus replication in mammalian cell-avian erythrocyte heterokaryons: studies concerning the actinomycin D and ultra-violet light sensitive phase in influenza virus replication.

N. Dimmock, D. Kelly, 1974, Virology.

Multiple mechanisms of neutralization of animal viruses

N. Dimmock, 1987 .

Comparison of the protection of ferrets against pandemic 2009 influenza A virus (H1N1) by 244 DI influenza virus and oseltamivir

M. Carroll, N. Dimmock, A. Easton, 2012, Antiviral research.

Defective interfering influenza A virus protects in vivo against disease caused by a heterologous influenza B virus.

N. Dimmock, A. Easton, A. Marriott, 2011, The Journal of general virology.

The genomic sequence of defective interfering Semliki Forest virus (SFV) determines its ability to be replicated in mouse brain and to protect against a lethal SFV infection in vivo.

C. White, N. Dimmock, M. Thomson, 1998, Virology.

Prevention of death in Semliki Forest virus-infected mice by administration of defective-interfering Semliki Forest virus.

N. Dimmock, S. Kennedy, 1978, The Journal of general virology.

Processing of exogenous poly(A) added to virus-infected cells.

N. Dimmock, S. Koliais, 1978, Biochemical and biophysical research communications.

Different patterns of polyadenylation of rhinovirus: specified RNA during multiplication in human aneuploid and diploid cells.

N. Dimmock, M. R. Macnaughton, 1976, The Journal of general virology.

Events Occurring Immediately After the Entry of the Microorganism

N. Dimmock, A. Nash, C. Mims, 1995, Mims' Pathogenesis of Infectious Disease.

Neutralization of influenza virus by low concentrations of hemagglutinin-specific polymeric immunoglobulin A inhibits viral fusion activity, but activation of the ribonucleoprotein is also inhibited

N. Dimmock, S. Armstrong, 1992, Journal of virology.

Dependence of the activity of an influenza virus neuraminidase upon Ca2+.

N. Dimmock, 1971, The Journal of general virology.

Morphological studies of the neutralization of influenza virus by IgM.

N. Dimmock, S. Armstrong, M. Outlaw, 1990, The Journal of general virology.

The complex antigenicity of a small external region of the C‐terminal tail of the HIV‐1 gp41 envelope protein: a lesson in epitope analysis

N. Dimmock, 2005, Reviews in medical virology.

The Spread of Microbes through the Body

N. Dimmock, A. Nash, C. Mims, 1995 .

A novel monoclonal antibody specific to the C-terminal tail of the gp41 envelope transmembrane protein of human immunodeficiency virus type 1 that preferentially neutralizes virus after it has attached to the target cell and inhibits the production of infectious progeny.

N. Dimmock, C. Heap, Steven A Reading, 2003, Virology.

Binding of an influenza A virus to a neomembrane measured by surface plasmon resonance.

Peter Critchley, N. Dimmock, P. Critchley, 2004, Bioorganic & medicinal chemistry.

Identification of a neutralization-specific antigen of a calf rotavirus.

N. Dimmock, H. Killen, 1982, The Journal of general virology.

Valency of Antibody Binding to Enveloped Virus Particles as Determined by Surface Plasmon Resonance

N. Dimmock, Sam A. Hardy, Nigel J. Dimmock, 2003, Journal of Virology.

IgG-neutralized influenza virus undergoes primary, but not secondary uncoating in vivo.

N. Dimmock, A. Carver, R. Rigg, 1989, The Journal of general virology.

Chemical crosslinking of proteins of the influenza virion

N. Dimmock, H. S. Dolbear, A. R. Guest, 1989, Archives of Virology.

Chemical cross-linking of proteins of the influenza virion

N. Dimmock, H. S. Dolbear, A. R. Guest, 2005, Archives of Virology.

Electrophoretic separation of influenza virus ribonucleoproteins.

N. Dimmock, P. Rees, 1981, The Journal of general virology.

An electron microscopic study of single-cycle infection of chick embryo fibroblasts by influenza virus.

R. Compans, N. Dimmock, 1969, Virology.

Mechanisms of neutralization of animal viruses.

N. Dimmock, 1984, The Journal of general virology.

Physicochemical properties of some viruses isolated from common colds (rhinoviruses).

D. Tyrrell, N. Dimmock, 1962, Lancet.

Intranasal immunization with a plant virus expressing a peptide from HIV-1 gp41 stimulates better mucosal and systemic HIV-1-specific IgA and IgG than oral immunization.

N. Dimmock, F. Brennan, T. Jones, 1998, Journal of immunological methods.

Analysis of the ability of five adjuvants to enhance immune responses to a chimeric plant virus displaying an HIV-1 peptide.

N. Dimmock, F. Brennan, T. Jones, 1999, Vaccine.

Determination of affinities of a panel of IgGs and Fabs for whole enveloped (influenza A) virions using surface plasmon resonance

N. Dimmock, D J Schofield, N J Dimmock, 1996, Journal of Virological Methods.

Protection of mice from lethal influenza by adoptive transfer of non-neutralizing haemagglutination-inhibiting IgG obtained from the lungs of infected animals treated with defective interfering virus.

N. Dimmock, L. McLain, 1989, The Journal of general virology.

Influence of the host cell on the genomic and subgenomic RNA content of defective-interfering influenza virus.

R. Avery, N. Dimmock, W. M. Crumpton, 1981, The Journal of general virology.

The RNAs of defective-interfering influenza virus.

R. Avery, N. Dimmock, P. Minor, 1978, Virology.

Characterization of putative defective interfering (DI) A/WSN RNAs isolated from the lungs of mice protected from an otherwise lethal respiratory infection with influenza virus A/WSN (H1N1): a subset of the inoculum DI RNAs.

N. Dimmock, S. Noble, 1995, Virology.

Heterogeneity of apparently empty poliovirus particles stained with phosphotungstic acid after heating of the virus at "low" temperature.

N. Dimmock, W. Harris, 1967, Virology.

Differences between the thermal inactivation of picornaviruses at "high" and "low" temperatures.

N. Dimmock, 1967, Virology.

COVID-19 Infection, Vaccines, and Immunity—The Antibody Response Requires Detailed Analysis

N. Dimmock, 2021, Microbiology Research.

Microbial Strategies in Relation to the Immune Response

N. Dimmock, A. Nash, C. Mims, 1995 .

Rhinovirus multistranded RNA: dependence of the replicative form on the presence of actinomycin D

N. Dimmock, M. R. Macnaughton, J. Cooper, 1976, Journal of virology.

Adenylic acid - rich sequences in influenza virus RNA.

R. Avery, N. Dimmock, M. R. Macnaughton, 1975, Biochemical and biophysical research communications.

Inhibition of the processing of ribosomal RNA in avian cells infected with an influenza virus.

J. Stephenson, N. Dimmock, 1974, Biochimica et biophysica acta.

Recovery from Infection

N. Dimmock, A. Nash, C. Mims, 1995, Mims' Pathogenesis of Infectious Disease.

Defective interfering influenza virus inhibits immunopathological effects of infectious virus in the mouse

N. Dimmock, D. J. Morgan, D J Morgan, 1992, Journal of virology.

Rhinovirus RNA Polymerase: Products and Kinetics of Appearance in Human Diploid Cells

N. Dimmock, S. Koliais, 1974, Journal of virology.

Replication of rhinovirus RNA.

N. Dimmock, S. Koliais, 1973, The Journal of general virology.

Camptothecin: an inhibitor of influenza virus replication.

R. Avery, N. Dimmock, D. Kelly, 1974, The Journal of general virology.

Neutralization of Animal Viruses

N. Dimmock, 1993, Current Topics in Microbiology and Immunology.

Mechanisms of neutralization of influenza virus by IgM.

N. Dimmock, H. P. Taylor, 1985, The Journal of general virology.

Studies on the mechanism of neutralization of influenza virus by antibody: evidence that neutralizing antibody (anti-haemagglutinin) inactivates influenza virus in vivo by inhibiting virion transcriptase activity.

G. Schild, N. Dimmock, R. Possee, 1982, The Journal of general virology.

Immunogenic and antigenic dominance of a nonneutralizing epitope over a highly conserved neutralizing epitope in the gp41 envelope glycoprotein of human immunodeficiency virus type 1: its deletion leads to a strong neutralizing response.

E. Buratti, F. Baralle, N. Dimmock, 2000, Virology.

Review article initial stages in infection with animal viruses.

N. Dimmock, N J Dimmock, 1982, The Journal of general virology.

Update on the neutralisation of animal viruses

N. Dimmock, N. J. Dimmock, 1995 .

The coupling of transcription from influenza virions to translationin vitro

N. Dimmock, P. Minor, 2005, Archives of Virology.

New virus-specific antigens in cells infected with influenza virus.

N. Dimmock, 1969, Virology.

The biological significance of defective interfering viruses

N. Dimmock, 1991 .

Persistence of virulent Semliki Forest virus in mouse brain following co-inoculation with defective interfering particles.

A. Barrett, N. Dimmock, A. Mackenzie, 1986, The Journal of general virology.

Protection of mice from lethal influenza: evidence that defective interfering virus modulates the immune response and not virus multiplication.

N. Dimmock, S. Beck, L. Mclain, 1986, The Journal of general virology.

Defective interfering viruses and infections of animals.

A. Barrett, N. Dimmock, 1986, Current topics in microbiology and immunology.

Protection of mice infected with a lethal dose of Semliki Forest virus by defective interfering virus: modulation of virus multiplication.

A. Barrett, N. Dimmock, A. Mackenzie, 1984, The Journal of general virology.

Modulation of a systemic Semliki Forest virus infection in mice by defective interfering virus.

A. Barrett, N. Dimmock, 1984, The Journal of general virology.

Modulation of Semliki Forest virus-induced infection of mice by defective-interfering virus.

A. Barrett, N. Dimmock, 1984, The Journal of infectious diseases.

Protection of three strains of mice against lethal influenza in vivo by defective interfering virus.

N. Dimmock, L. McLain, D. J. Morgan, 1993, Virus research.

Differential effects of defective interfering Semliki Forest virus on cellular and virus polypeptide synthesis.

A. Barrett, N. Dimmock, 1985, Virology.

Defective interfering Semliki Forest virus populations are biologically and physically heterogeneous.

A. Barrett, N. Dimmock, C. Crouch, 1984, The Journal of general virology.

Properties of host and virus which influence defective interfering virus mediated-protection of mice against Semliki Forest virus lethal encephalitis

A. Barrett, N. Dimmock, 2005, Archives of Virology.

Defective interfering particles of Semliki Forest virus are smaller than particles of standard virus.

A. Barrett, N. Dimmock, W. Cubitt, 1984, The Journal of general virology.

A preliminary study of physiological characteristics of temperature-sensitive mutants of influenza virus.

J. Mackenzie, N. Dimmock, 1973, The Journal of general virology.

Live Attenuated Influenza Vaccine contains Substantial and Unexpected Amounts of Defective Viral Genomic RNA

N. Dimmock, A. Easton, P. Gould, 2017, Viruses.

Defective interfering influenza virus confers only short-lived protection against influenza virus disease: Evidence for a role for adaptive immunity in DI virus-mediated protection in vivo

N. Dimmock, A. Easton, A. Marriott, 2011, Vaccine.

A novel broad-spectrum treatment for respiratory virus infections: influenza-based defective interfering virus provides protection against pneumovirus infection in vivo.

Nicole L Edworthy, N. Dimmock, A. Easton, 2011, Vaccine.

Interfering vaccine (defective interfering influenza A virus) protects ferrets from influenza, and allows them to develop solid immunity to reinfection.

J. Oxford, A. Mann, S. Balasingam, 2006, Vaccine.

In vivo antiviral activity: defective interfering virus protects better against virulent Influenza A virus than avirulent virus.

N. Dimmock, A. Marriott, 2006, The Journal of general virology.

Subclinical infections in mice resulting from the modulation of a lethal dose of Semliki Forest virus with defective interfering viruses: neurochemical abnormalities in the central nervous system.

T. Crow, A. Barrett, A. Cross, 1986, The Journal of general virology.

Failure of an Influenza Virus to Initiate Infection in Enucleate BHK cells

R. Avery, N. Dimmock, D. Kelly, 1974, Journal of virology.

Differential distribution of influenza virus P proteins in nuclei of infected cells

R. F. Cook, R. Avery, N. Dimmock, 1979 .

Early events in influenza virus infection. III. The formation of a nucleoplasmic ribonucleoprotein complex from the input virion.

N. Dimmock, J. Hudson, J. Flawith, 1978, Virology.

Selective inhibition of influenza virus protein synthesis by inhibitors of DNA function.

N. Dimmock, P. Minor, 1977, Virology.

Inhibition of synthesis of influenza virus proteins: evidence of two host-cell-dependent events during multiplication.

N. Dimmock, P. Minor, 1975, Virology.

Failure ofanInfluenza Virus toInitiate Infection inEnucleate BHK cells

R. Avery, N. Dimmock, D. Kelly, 1974 .

Early events in influenza virus multiplication. I. Location and fate of the input RNA.

J. Stephenson, N. Dimmock, 1975, Virology.

Kinetics of synthesis of influenza virus ribonucleoprotein structures.

N. Dimmock, P. Rees, 1982, The Journal of general virology.

Complementation with an avian influenza virus is required for synthesis of M protein of a human strain in chicken erythrocytes

R. F. Cook, R. Avery, N. Dimmock, 2005, Archives of Virology.

Influence of the host cell on proteins synthesized by different strains of influenza virus.

N. Dimmock, P. Minor, J. Hart, 1979, Virology.

Infection of chicken erythrocytes with influenza and other viruses

R. F. Cook, R. Avery, N. Dimmock, 1979, Infection and immunity.

The multiplication of influenza virus in enucleated BHK cells fused with chicken erythrocytes.

N. Dimmock, P. Minor, 1976, Virology.

Newly synthesized influenza virus proteins are transported from the nucleus.

N. Dimmock, J. Flawith, 1979, The Journal of general virology.

Internal proteins of influenza virus: 35S-methionine peptide maps as genetic markers.

N. Dimmock, S. Kennedy, S. Luscombe, 1977, The Journal of general virology.

The use of nuclear monolayers in the study of influenza virus-infected cells

N. Dimmock, J. Hudson, 1977 .

NEUTRALIZATION OF INFLUENZA VIRUS BY ANTIBODY: ATTACHMENT, UPTAKE AND UNCOATING OF NEUTRALIZED VIRUS IN CHICK EMBRYO CELLS

N. Dimmock, R. Possee, 1981 .

Early events in influenza virus multiplication. II. Penetration of virus into cells at 4 degrees.

J. Stephenson, N. Dimmock, J. Hudson, 1978, Virology.

Temporal control of transcription of influenza virus RNA.

R. Avery, N. Dimmock, 1975, Virology.

Biophysical Studies of a Rhinovirus: Extraction and Assay of Infectious Ribonucleic Acid

N. Dimmock, 1966, Nature.

Analysis of the relationship between immunogenicity and immunity for viral subunit vaccines

D. Nokes, N. Dimmock, D. Nokes, 2001, Journal of medical virology.

Influenza Virus Protecting RNA: an Effective Prophylactic and Therapeutic Antiviral

N. Dimmock, A. Marriott, P. Scott, 2008, Journal of Virology.

Studies on antigenic variations of the haemagglutinin and neuraminidase of swine influenza virus isolates.

N. Dimmock, H. Meier-Ewert, 1970, The Journal of general virology.

Heterologous protection of mice from a lethal human H1N1 influenza A virus infection by H3N8 equine defective interfering virus: comparison of defective RNA sequences isolated from the DI inoculum and mouse lung.

N. Dimmock, S. Duhaut, 1998, Virology.

A region of the C-terminal tail of the gp41 envelope glycoprotein of human immunodeficiency virus type 1 contains a neutralizing epitope: evidence for its exposure on the surface of the virion.

N. Dimmock, Mark J Hollier, L. Cheung, 2003, The Journal of general virology.

Two influenza A virus-specific Fabs neutralize by inhibiting virus attachment to target cells, while neutralization by their IgGs is complex and occurs simultaneously through fusion inhibition and attachment inhibition.

N. Dimmock, M. Edwards, 2000, Virology.

Properties of a neutralizing antibody that recognizes a conformational form of epitope ERDRD in the gp41 C-terminal tail of human immunodeficiency virus type 1.

N. Dimmock, T D Jones, N J Dimmock, 2000, The Journal of general virology.

Properties and mechanism of action of a 17 amino acid, V3 loop-specific microantibody that binds to and neutralizes human immunodeficiency virus type 1 virions.

B. Wahrén, N. Dimmock, M. Levi, 1999, The Journal of general virology.

Rapid analysis of epitope-paratope interactions between HIV-1 and a 17-amino-acid neutralizing microantibody by electrospray ionization mass spectrometry.

A. Millar, B. Wahrén, N. Dimmock, 1998, European journal of biochemistry.

A human IgG1 (b12) specific for the CD4 binding site of HIV-1 neutralizes by inhibiting the virus fusion entry process, but b12 Fab neutralizes by inhibiting a postfusion event.

N. Dimmock, S. Armstrong, L. McLain, 1997, Virology.

Two neutralizing anti-V3 monoclonal antibodies act by affecting different functions of human immunodeficiency virus type 1.

B. Wahrén, N. Dimmock, S. Armstrong, 1996, The Journal of general virology.

Common sequence elements in structurally unrelated genomes of defective interfering Semliki Forest virus.

N. Dimmock, M. Thomson, 1994, Virology.

Interfering vaccine: a novel antiviral that converts a potentially virulent infection into one that is subclinical and immunizing.

N. Dimmock, S. Noble, L. McLain, 2004, Vaccine.

The C-terminal tail of the gp41 transmembrane envelope glycoprotein of HIV-1 clades A, B, C, and D may exist in two conformations: an analysis of sequence, structure, and function

N. Dimmock, Mark J Hollier, Nigel J Dimmock, 2005, Virology.

Assay of defective-interfering semliki forest virus by the inhibition of synthesis of virus-specified RNAs.

A. Barrett, N. Dimmock, C. Crouch, 1981, The Journal of general virology.

Human immunodeficiency virus type 1-neutralizing antibodies raised to a glycoprotein 41 peptide expressed on the surface of a plant virus.

G. Lomonossoff, N. Dimmock, C. Porta, 1995, AIDS research and human retroviruses.

Single- and multi-hit kinetics of immunoglobulin G neutralization of human immunodeficiency virus type 1 by monoclonal antibodies.

N. Dimmock, L. McLain, 1994, The Journal of general virology.

Understanding the SARS-CoV-2 Virus Neutralizing Antibody Response: Lessons to Be Learned from HIV and Respiratory Syncytial Virus

N. Dimmock, A. Easton, 2023, Viruses.

RNAs of influenza C virus strains

N. Dimmock, H. Meier-Ewert, T. Petri, 2005, Archives of Virology.

Unexpected complexity in the interference activity of a cloned influenza defective interfering RNA

N. Dimmock, A. Easton, A. Marriott, 2017, Virology Journal.

Cloned Defective Interfering Influenza RNA and a Possible Pan-Specific Treatment of Respiratory Virus Diseases

N. Dimmock, A. Easton, 2015, Viruses.

Defective influenza A virus generated entirely from plasmids: its RNA is expressed in infected mouse lung and modulates disease.

N. Dimmock, S. Duhaut, 2003, Journal of virological methods.

Analysis of a 17-amino acid residue, virus-neutralizing microantibody.

T. Pinheiro, N. Dimmock, C. Heap, 2005, The Journal of general virology.

Hemagglutinin 1-Specific Immunoglobulin G and Fab Molecules Mediate Postattachment Neutralization of Influenza A Virus by Inhibition of an Early Fusion Event

N. Dimmock, M. Edwards, 2001, Journal of Virology.

Varying temperature-dependence of post-attachment neutralization of human immunodeficiency virus type 1 by monoclonal antibodies to gp 120: identification of a very early fusion-independent event as a neutralization target.

N. Dimmock, S. Armstrong, 1996, The Journal of general virology.

Neutralization escape mutants of type A influenza virus are readily selected by antisera from mice immunized with whole virus: a possible mechanism for antigenic drift.

N. Dimmock, R Lambkin, N J Dimmock, 1994, The Journal of general virology.

Neutralization of Poliovirus and Rhinovirus: A Summary

N. Dimmock, 1993 .

Increasing the efficiency of virus infectivity assays: small inoculum volumes are as effective as centrifugal enhancement.

N. Dimmock, Steven A Reading, M. Edwards, 2001, Journal of virological methods.

Low Dose Influenza Virus Challenge in the Ferret Leads to Increased Virus Shedding and Greater Sensitivity to Oseltamivir

W. Barclay, M. Carroll, N. Dimmock, 2014, PloS one.

Effect of Antibody to Neuraminidase on the Maturation and Hemagglutinating Activity of an Influenza A2 Virus

R. Compans, N. Dimmock, H. Meier-Ewert, 1969, Journal of virology.

The effect of defective-interfering Semliki Forest virus on the histopathology of infection with virulent Semliki Forest virus in mice.

N. Dimmock, A. Mackenzie, C. Crouch, 1982, The Journal of infectious diseases.

Polyadenylic acid sequences in rhinovirus RNA species from infected human diploid cells

N. Dimmock, M. R. Macnaughton, 1975, Journal of Virology.

Mechanisms of neutralization of a nairovirus (Dugbe virus) by polyclonal IgG and IgM.

N. Dimmock, S. Armstrong, E. M. Green, 1992, Journal of General Virology.

A rapid method for the inactivation of virus infectivity prior to assay for interferons.

A. Barrett, N. Dimmock, N. Hunt, 1984, Journal of virological methods.

The role of the neuraminidase of the infecting virus in the production of noninfectious (von Magnus) influenza virus.

N. Dimmock, H. Meier-Ewert, 1970, Virology.

Different effects of a single amino acid substitution on three adjacent epitopes in the gp41 C-terminal tail of a neutralizing antibody escape mutant of human immunodeficiency virus type 1

N. Dimmock, Steven A Reading, L. Cheung, 2001, Archives of Virology.

Longitudinal study of an epitope-biased serum haemagglutination-inhibition antibody response in rabbits immunized with type A influenza virions.

N. Dimmock, R. Lambkin, 1996, Vaccine.

All rabbits immunized with type A influenza virions have haemagglutination-inhibition antibody response biased to in antigenic site B a serum a single epitope

N. Dimmock, R. Lambkin, 1995 .

The neutralizing antibody response against a conserved region of human immunodeficiency virus type 1 gp41 (amino acid residues 731-752) is uniquely directed against a conformational epitope.

E. Buratti, F. Baralle, N. Dimmock, 1998, The Journal of general virology.

Selection of neutralizing antibody escape mutants with type A influenza virus HA-specific polyclonal antisera: possible significance for antigenic drift

N. Dimmock, H. P. Taylor, N J Dimmock, 1997, Epidemiology and Infection.

Polymorphism of the NS1 proteins of type A influenza virus.

N. Dimmock, S. Patterson, T. Petri, 1982, The Journal of general virology.

A haemagglutinin (HA1)-specific FAb neutralizes influenza A virus by inhibiting fusion activity.

N. Dimmock, N J Dimmock, M J Edwards, 2001, The Journal of general virology.

Production of long-lived neutralizing antibodies to HIV-1 IIIB in mice with a vaccinia recombinant virus-infected cell vaccine expressing gp160.

N. Dimmock, L. McLain, C. Parry, 1994, AIDS research and human retroviruses.

Neutralization titres of HIV-1-specific monoclonal antibodies vary according to the batch of primary human peripheral blood lymphocytes, but do not vary coordinately.

N. Dimmock, S. Armstrong, L. McLain, 1997, Journal of virological methods.

High and low efficiency neutralization epitopes on the haemagglutinin of type A influenza virus.

J. Stephenson, N. Dimmock, D. Schofield, 1997, The Journal of general virology.

Inhibition of Rhinovirus RNA Synthesis in Diploid Cells by a Substituted Guanidine Compound having a different Mode of Action from Guanidine

N. Dimmock, S. Koliais, 1974 .

Defective interfering type A equine influenza virus (H3N8) protects mice from morbidity and mortality caused by homologous and heterologous subtypes of influenza A virus.

N. Dimmock, S. Noble, 1994, The Journal of general virology.

INTERACTION OF NEUTRALIZED INFLUENZA VIRUS WITH AVIAN AND MAMMALIAN CELLS

N. Dimmock, H. P. Taylor, A. Carver, 1984 .

Variation in homotypic and heterotypic interference by defective interfering viruses derived from different strains of Semliki Forest virus and from Sindbis virus.

A. Barrett, N. Dimmock, 1984, The Journal of general virology.

One defective interfering particle per cell prevents influenza virus-mediated cytopathology: an efficient assay system.

N. Dimmock, S. Armstrong, N J Dimmock, 1988, Journal of General Virology.